Canada markets open in 1 hour 13 minutes

Creo Medical Group PLC (1RC.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.4000-0.0040 (-0.99%)
As of 01:36PM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 154.17M
Enterprise Value 142.25M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.51
Price/Book (mrq)2.09
Enterprise Value/Revenue 3.95
Enterprise Value/EBITDA -2.58

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 346.38%
S&P500 52-Week Change 328.04%
52 Week High 30.5350
52 Week Low 30.2580
50-Day Moving Average 30.3912
200-Day Moving Average 30.3874

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5361.48M
Implied Shares Outstanding 6381.61M
Float 8308.09M
% Held by Insiders 120.86%
% Held by Institutions 145.13%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -70.46%
Operating Margin (ttm)-75.50%

Management Effectiveness

Return on Assets (ttm)-20.40%
Return on Equity (ttm)-39.74%

Income Statement

Revenue (ttm)30.8M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)11.60%
Gross Profit (ttm)N/A
EBITDA -21.4M
Net Income Avi to Common (ttm)-21.7M
Diluted EPS (ttm)-0.0800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.5M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)8.3M
Total Debt/Equity (mrq)13.88%
Current Ratio (mrq)3.83
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)-21.6M
Levered Free Cash Flow (ttm)-17.83M